Putnam Investments’s Trinity Biotech TRIB Stock Holding History

Putnam Investments’s Portfolio TRIB Stock Details TRIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-9,999	Closed	-$903K	–	1537
2015 Q2	$903K	Sell	9,999 -82	-0.8%	-$7.1K	﹤0.01%	1241
2015 Q1	$970K	Sell	10,081 -356	-3%	-$32.9K	﹤0.01%	1205
2014 Q4	$913K	Sell	10,437 -4,419	-30%	-$381K	﹤0.01%	1195
2014 Q3	$1.36M	Buy	14,856 +247	+2%	+$26.7K	﹤0.01%	1137
2014 Q2	$1.68M	Buy	14,609 +17	+0.1%	+$2.02K	﹤0.01%	1072
2014 Q1	$1.77M	Sell	14,592 -745	-5%	-$97.7K	﹤0.01%	1074
2013 Q4	$1.93M	Sell	15,337 -226	-1%	-$27.1K	﹤0.01%	1058
2013 Q3	$1.69M	Sell	15,563 -1,371	-8%	-$134K	﹤0.01%	1105
2013 Q2	$1.43M	Buy	+16,934	New	+$1.4M	﹤0.01%	1142

Other funds holding TRIB

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

AAM

ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Putnam Investments's TRIB Position: Q3 2015 in Review

Putnam Investments sold out of Trinity Biotech (TRIB) in Q3 2015, closing a stake of 9,999 shares — an estimated $903K sold.

Putnam Investments first reported a position in TRIB in Q2 2013 and held it in 9 quarters. The position peaked at $1.93M in Q4 2013. 92 funds tracked by Wall St. Rank hold TRIB as of Q3 2015.

Putnam Investments reported no remaining Trinity Biotech position as of Q3 2015 after selling out during the quarter.
Putnam Investments sold 9,999 Trinity Biotech shares in Q3 2015, an estimated $903K.
Putnam Investments first reported a position in Trinity Biotech in Q2 2013 and held it in 9 quarters.
Putnam Investments's Trinity Biotech position peaked at $1.93M in Q4 2013.
92 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2015.

Based on Putnam Investments's 13F filing for Q3 2015, filed 16 Nov 2015.